Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Triple-Hormone-Receptor Agonist Retatrutide for Obesity phase 2 trial
Male germ cell-specific knockout of cholesterogenic cytochrome P450 lanosterol 14-demethylase (Cyp51)
Abstract Obesity is a systemic metabolic disorder that is inducing factor for other diseases such as diabetes mellitus, cardiovascular diseases, malignancies, hepatic dysfunction, renal dysfunction and endometrial diseases
Limited data exist regarding tirzepatide's effects on other inflammatory markers such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-) in humans, with most evidence coming from preclinical studies
US$ 23.79
US$ 21.83
US$ 21.19
US$ 24.01
US$ 22.09
US$ 20.10
US$ 25.18
